AZN.UK

11,356

+0.42%↑

GSK

1,468.5

+0.27%↑

STJ

1,245.5

+0.65%↑

HIK

1,616

+0.25%↑

AZN.UK

11,356

+0.42%↑

GSK

1,468.5

+0.27%↑

STJ

1,245.5

+0.65%↑

HIK

1,616

+0.25%↑

AZN.UK

11,356

+0.42%↑

GSK

1,468.5

+0.27%↑

STJ

1,245.5

+0.65%↑

HIK

1,616

+0.25%↑

AZN.UK

11,356

+0.42%↑

GSK

1,468.5

+0.27%↑

STJ

1,245.5

+0.65%↑

HIK

1,616

+0.25%↑

AZN.UK

11,356

+0.42%↑

GSK

1,468.5

+0.27%↑

STJ

1,245.5

+0.65%↑

HIK

1,616

+0.25%↑

Search

Haleon PLC

Închisă

SectorSănătate

342.6 0.47

Rezumat

Modificarea prețului

24h

Curent

Minim

340.2

Maxim

343.6

Indicatori cheie

By Trading Economics

Venit

172M

403M

Vânzări

-19M

2.7B

P/E

Medie Sector

20.982

35.293

Randament dividend

1.88

Marjă de profit

14.708

Angajați

24,561

EBITDA

17M

697M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+18.95% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.88%

3.07%

Data viitoare de dividende

18 sept. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-3.2B

32B

Deschiderea anterioară

342.13

Închiderea anterioară

342.6

Sentimentul știrilor

By Acuity

60%

40%

341 / 371 Clasament în Healthcare

Haleon PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 iul. 2025, 08:02 UTC

Câștiguri
Principalele dinamici ale pieței

Haleon Shares Fall on Cut to Organic Revenue Guidance

31 iul. 2025, 07:03 UTC

Câștiguri

Haleon Raises 2025 Profit Guidance, Cuts Revenue Growth Targets

15 apr. 2025, 09:37 UTC

Achiziții, Fuziuni, Preluări

Haleon Acquires Chinese JV in $264 Million Deal

31 iul. 2025, 06:14 UTC

Câștiguri

Analysts Saw Haleon 1H Adjusted PBT at GBP1.10B

31 iul. 2025, 06:14 UTC

Câștiguri

Haleon 1H Adjusted PBT GBP1.11B

31 iul. 2025, 06:12 UTC

Câștiguri

Haleon Declares 1H Dividend of 2.2 Pence

31 iul. 2025, 06:11 UTC

Câștiguri

Haleon: Targets High-single Digit Adjusted Operating Profit Growth from 2026

31 iul. 2025, 06:10 UTC

Câștiguri

Haleon: From 2026 Targets 4%-6% Annual Organic Revenue Growth

31 iul. 2025, 06:09 UTC

Câștiguri

Haleon: Targets High-Single Digit Organic Operating Profit Growth in 2025

31 iul. 2025, 06:08 UTC

Câștiguri

Haleon: Lowers Guidance to 2025 Organic Revenue at Around 3.5%

31 iul. 2025, 06:05 UTC

Câștiguri

Haleon 1H Free Cash Flow GBP734M

31 iul. 2025, 06:05 UTC

Câștiguri

Haleon 1H Adjusted Operating Profit Margin 22.7%

31 iul. 2025, 06:05 UTC

Câștiguri

Haleon 1H Adjusted Operating Profit GBP1.24B

31 iul. 2025, 06:02 UTC

Câștiguri

Analysts Saw Haleon 1H Rev GBP5.50B

31 iul. 2025, 06:02 UTC

Câștiguri

Haleon 1H Rev GBP5.48B

27 iun. 2025, 09:05 UTC

Achiziții, Fuziuni, Preluări

Haleon: TSKF Is Now a Wholly Owned Unit of Haleon

27 iun. 2025, 09:05 UTC

Achiziții, Fuziuni, Preluări

Haleon: Acquired Remaining Stake for GBP0.2 Billion

27 iun. 2025, 09:03 UTC

Achiziții, Fuziuni, Preluări

Haleon: Bought Remaining 12% Equity Interest in Tianjin TSKF Pharmaceutical

27 iun. 2025, 09:01 UTC

Achiziții, Fuziuni, Preluări

Haleon Completed Acquisition of Remaining 12% in China JV

30 mai 2025, 13:47 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Consumer Health Sector Has Room for More Dealmaking -- Market Talk

30 apr. 2025, 08:33 UTC

Market Talk
Câștiguri

Haleon's Vitamins & Supplements Business Weakness in Focus Among Results -- Market Talk

30 apr. 2025, 06:09 UTC

Câștiguri

Haleon Expects Macroeconomic Environment to Remain Challenging, Uncertain

30 apr. 2025, 06:09 UTC

Câștiguri

Haleon Continues to Deliver Against Capital Allocation Priorities

30 apr. 2025, 06:08 UTC

Câștiguri

Analysts Saw Haleon 1Q Organic Revenue Growth at 5.1%

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon Sees 2025 Adjusted Operating Profit Growth Ahead of Revenue Growth

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon Backs 2025 View

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon 1Q Rev GBP2.85B

30 apr. 2025, 06:01 UTC

Câștiguri

Haleon 1Q Organic Revenue Growth up 3.5%

29 apr. 2025, 19:47 UTC

Câștiguri

Pfizer Shares Rise on CEO's Optimism on Threatened Drug Tariffs -- Barrons.com

Comparație

Modificare preț

Haleon PLC Așteptări

Obiectiv de preț

By TipRanks

18.95% sus

Prognoză pe 12 luni

Medie 424.29 GBX  18.95%

Maxim 500 GBX

Minim 370 GBX

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHaleon PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

8 ratings

5

Cumpărare

2

Păstrare

1

Vânzare

Sentiment

By Acuity

341 / 371 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
help-icon Live chat